GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Capex-to-Operating-Cash-Flow

Wright Medical Group NV (Wright Medical Group NV) Capex-to-Operating-Cash-Flow : 0.63 (As of Sep. 2020)


View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Wright Medical Group NV's Capital Expenditure for the three months ended in Sep. 2020 was $-13.41 Mil. Its Cash Flow from Operations for the three months ended in Sep. 2020 was $21.35 Mil.

Hence, Wright Medical Group NV's Capex-to-Operating-Cash-Flow for the three months ended in Sep. 2020 was 0.63.


Wright Medical Group NV Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Wright Medical Group NV's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Capex-to-Operating-Cash-Flow Chart

Wright Medical Group NV Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.45 - - 2.59

Wright Medical Group NV Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.59 1.38 - 0.63

Competitive Comparison of Wright Medical Group NV's Capex-to-Operating-Cash-Flow

For the Medical Devices subindustry, Wright Medical Group NV's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group NV's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's Capex-to-Operating-Cash-Flow falls into.



Wright Medical Group NV Capex-to-Operating-Cash-Flow Calculation

Wright Medical Group NV's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2019 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-107.734) / 41.607
=2.59

Wright Medical Group NV's Capex-to-Operating-Cash-Flow for the quarter that ended in Sep. 2020 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-13.407) / 21.346
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wright Medical Group NV  (NAS:WMGI) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Wright Medical Group NV Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group NV (Wright Medical Group NV) Business Description

Traded in Other Exchanges
N/A
Address
Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.
Executives
Steven P. Wallace officer: President, International 1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan officer: SVP, Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith officer: SVP, Quality and Regulatory 1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper officer: SVP, Chief Digital Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier officer: President, Upper Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher officer: President, Lower Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter officer: SVP, Chief Compliance Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews officer: SVP, Global Finance 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker officer: SVP, Process Improvement 5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton officer: SVP, Chief Human Resources Ofr 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry officer: EVP, Chief Finan./Op. Officer 5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey officer: SVP, Chief Comm. Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell officer: EVP, Chief Global Comm Officer C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano director, officer: President and Chief Executive 110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke officer: Pres. Emerging Markets AUS/JAP 5677 AIRLINE ROAD ARLINGTON TN 38002